D-0492-2019 Class III Terminated

Recalled by Oxalis Labs — Theda, N/A

FDA drug recall D-0492-2019 was initiated by Oxalis Labs on Jan 11, 2019 and is designated Class III. Reason for recall: Defective Container; complaints of leakage. The recall status is terminated (terminated Nov 6, 2019). Affected quantity: 53,358 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 20, 2019
Initiation Date
Jan 11, 2019
Termination Date
Nov 6, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
53,358 bottles

Product description

Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86

Reason for recall

Defective Container; complaints of leakage.

Distribution pattern

Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States.

Code information

Lot Numbers: PCA801A, PCA802A, PCA803A, exp. date 12/2019; PCA804A, PCA805A, PCA806A, PCA807A, exp. date 04/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0492-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0492-2019. Report a data issue: hello@regdatalab.com.